Home > News > Diversa Granted U.S. Patent
August 11th, 2003
Diversa Granted U.S. Patent
Diversa Corporation (Nasdaq: DVSA) today announced that it has been issued U.S. Patent No. 6,602,675, expanding its proprietary position for identifying biologically active molecules from the environment. The patent is directed to small molecule and enzyme discovery from both cultured and uncultured filamentous fungi and bacteria using high-throughput fluorescent screening. In addition to their utility for discovering novel enzyme products for agricultural and chemical applications, the technologies covered in this patent are an important part of Diversa’s small molecule discovery platform, which includes high-throughput culturing and recombinant expression for developing natural product drug candidates.
onic Present breakthrough in CMOS-based Transceivers for mm-Wave Radar Systems March 1st, 2015
New Paper-like Material Could Boost Electric Vehicle Batteries: Researchers create silicon nanofibers 100 times thinner than human hair for potential applications in batteries for electric cars and personal electronics February 20th, 2015
Nanotech Discoveries Move from Lab to Marketplace with Lintec Deal: Licensing Partnership Brings Together University Technology, New Richardson-Based Facility Directed by Alumni February 9th, 2015
Graphenea granted patent on graphene transfer February 9th, 2015